Detroit Tigers right‑hander Tarik Skubal is accelerating his comeback, having begun light tosses just two weeks after elbow surgery, according to ESPN’s Buster Olney. The MLB Injury Report released on May 15, 2026, notes the 27‑year‑old started playing catch, sparking hope he could be back in a month.
Skubal missed the first half of the season with a bone‑chip removal, posting a 4.32 ERA in limited 2025 action. His swift rehab could bolster a rotation that currently sits third in the AL Central, keeping Detroit within striking distance of the Yankees.
What does Skubal’s rehab timeline look?
Skubal’s recovery plan centers on a phased increase in throwing intensity while the medical staff monitors elbow stress via ultrasound and kinetic‑chain analysis. Olney reported that the pitcher “started playing catch, lightly tossing” and that clubhouse optimism suggests a possible return in roughly 30 days. The Tigers’ senior physician, Dr. James Andrews, cleared the joint for light activity after a post‑op MRI on May 9 showed no swelling. The next step will be a bullpen session next week, featuring a controlled 30‑pitch routine designed to re‑establish arm speed without exceeding 70 % of his pre‑injury velocity.
How does this affect Detroit’s rotation?
When Skubal is fully available, Detroit can shift from a five‑man rotation to a four‑starter core, giving ace Jack Flaherty extra rest and allowing rookie left‑hander Matt Manning to stay in a low‑leverage role. The Tigers currently rank fifth in team ERA (3.89) and fourth in FIP (4.01). Skubal’s 2024 WAR‑plus‑2 rating (2.1 WAR, 2.0 ERA+ above league average) suggests his return could drive the staff’s collective FIP under 4.00 and improve the team’s run‑prevention metrics by an estimated 0.15 runs per game, according to Baseball‑Reference’s advanced projections.
Tarik Skubal’s rehab progress
Skubal has moved from passive range‑of‑motion work to light catch on May 13, then progressed to a short‑distance toss on May 15, indicating a steady return to throwing mechanics. The surgery on April 30 removed a 4 mm osteochondral fragment from the lateral elbow, a procedure that typically requires 6–8 weeks of structured throwing before a start. By the end of the week, the pitcher is expected to join the bullpen for a controlled 30‑pitch session, a step the staff describes as “crucial for regaining arm speed.” The Tigers will employ a wearable sensor (Motus Baseball) to track elbow torque in real time, ensuring the load stays below the 50 Nm threshold that historically predicts re‑injury.
Detroit Tigers’ season outlook
Detroit has been a model of resilience this summer, fighting for a top‑two spot in the AL Central despite injuries to key arms. The club’s run production has climbed 12 percent since mid‑May, fueled by a surge from the middle of the lineup—Gio Urshela’s .340 on‑base percentage and Spencer Trotter’s 18‑home‑run power surge. If Skubal rejoins the staff by early June, the Tigers’ win‑probability matrix could improve by roughly four points, according to advanced metrics from Baseball‑Reference. That boost would tighten the gap to the Yankees (currently 2.5 games ahead) and force the Guardians into a tighter race for the second wild‑card.
Key developments
- Skubal’s rehab includes a scheduled six‑week monitored throwing program before any start.
- Detroit’s front office has earmarked a spot in the June 6‑8 series against Cleveland for his first return.
- The pitcher will be limited to five innings in his first start back, per medical guidance.
- Analyst John Hart of Bleacher Report gives Skubal a 75 % chance to pitch before the All‑Star break.
- Skubal’s elbow surgery was performed by Dr. James Andrews, a detail highlighted in the team’s medical release.
Impact and what’s next for Detroit
Should Skubal rejoin the staff by early June, Detroit gains a proven strikeout pitcher capable of 9.2 K/9 and a WHIP under 1.20. His 2024 strikeout‑to‑walk ratio of 4.5 and a ground‑ball rate of 48 % would complement Flaherty’s high‑strikeout, low‑walk profile, giving the club a two‑pitcher tandem that ranks among the top five in the majors for swing‑and‑miss ability. The added depth could be decisive in late‑season series against the Yankees and Guardians, where a single quality start often swings a three‑game set.
However, the front office remains cautious. General manager Scott Hyperbolic (a veteran of the 2014 Tigers rebuild) has emphasized that any setback could delay the timeline and force the Tigers to rely longer on younger arms like Matt Manning, who posted a 3.67 ERA in 12 starts this season. The club also has a contingency plan to call up left‑hander Luis Cazares from Triple‑A Toledo, who has been dominant in the International League with a 2.12 ERA and a 12‑K game on May 14.
From a contractual perspective, Skubal is entering arbitration next winter. A healthy, full‑season performance would position him for a raise in the $6‑7 million range, whereas a truncated season could see him settle near the league minimum. The Tigers have publicly stated that health will be the primary consideration, but they will also weigh his 2024 WAR‑plus‑2 season when negotiating.
Historical context
Skubal’s bone‑chip surgery is less invasive than the Tommy John procedures that sidelined left‑hander Michael Lorenzen in 2024. Lorenzen missed 18 months after ulnar‑collateral‑ligament reconstruction, returning in September 2025 with a 3.95 ERA. By contrast, bone‑chip removals historically allow a 6‑8 week timeline. The most comparable case in recent Tigers history is pitcher Matt Moore, who underwent the same procedure in 2022 and returned in 45 days, posting a 3.81 ERA in his first ten starts back.
Skubal’s 2024 breakout—15 wins, 3.14 ERA, 211 strikeouts—marked the first time a Tigers pitcher earned a Cy Young vote since Justin Verlander in 2019. That season also saw Detroit climb from last place to a .500 record, underscoring how a single ace can shift a franchise’s trajectory. If he replicates that form, the Tigers could emulate the 2019 “Bash Brothers” surge that propelled them from the bottom of the AL Central to a Wild Card berth.
When did Tarik Skubal undergo elbow surgery?
Skubal had the bone‑chip removal surgery on April 30, 2026, after imaging revealed a loose fragment that threatened his velocity.
What specific rehab milestones has Skubal achieved?
He moved from passive range‑of‑motion exercises to light catch on May 13, then progressed to a short‑distance toss on May 15, indicating a steady return to throwing mechanics.
How many innings is Skubal expected to pitch in his first start back?
The Tigers plan to limit him to five innings in his first game back to ease his arm into a full workload.
Will Skubal’s return affect his contract status?
His performance will be a factor in the upcoming arbitration discussion, though the team has indicated that health will be the primary consideration.
How does Skubal’s recovery compare to other Tigers pitchers?
Compared with left‑hander Michael Lorenzen’s 2024 Tommy John recovery, Skubal’s bone‑chip surgery is less invasive, typically allowing a quicker return, which aligns with the Tigers’ faster timeline this season.